| Market Cap | ₹3,156Cr |
| ROE | 0.77% |
| P/E Ratio(TTM) | 440.90 |
| EPS(TTM) | 3.06 |
| P/B Ratio | 4.27 |
| Dividend Yield | 0.07% |
| Industry P/E | 43.88 |
| Book Value | 315.84 |
| Debt to Equity | 0.05 |
| Face Value | 10 |
| Parent Organisation | Tatva Chintan Pharma Chem |
| Managing Director | Mr. Chintan Shah |
| NSE Symbol | TATVA |
| FUND NAME | AUM(%) |
|---|---|
| Nippon India ELSS Tax Saver Fund Direct Growth | 0.38% |
| ICICI Prudential Smallcap Fund Direct Plan Growth | 0.12% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Foseco India | NA (0.00%) | 44.15 | ||
| Fineotex Chemical | NA (0.00%) | 27.91 | ||
| Paushak | NA (0.00%) | 34.97 | ||
| Jyoti Resins & Adhesives | NA (0.00%) | 21.02 |